173 related articles for article (PubMed ID: 33023572)
1. LncRNA NEAT1 mediates progression of oral squamous cell carcinoma via VEGF-A and Notch signaling pathway.
He K; Zhu ZB; Shu R; Hong A
World J Surg Oncol; 2020 Oct; 18(1):261. PubMed ID: 33023572
[TBL] [Abstract][Full Text] [Related]
2. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway.
Liu Z; Li H; Fan S; Lin H; Lian W
Cancer Biol Ther; 2019; 20(4):444-453. PubMed ID: 30404566
[TBL] [Abstract][Full Text] [Related]
3. LncRNA NEAT1 affects inflammatory response by targeting miR-129-5p and regulating Notch signaling pathway in epilepsy.
Wan Y; Yang ZQ
Cell Cycle; 2020 Feb; 19(4):419-431. PubMed ID: 31948324
[TBL] [Abstract][Full Text] [Related]
4. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
[TBL] [Abstract][Full Text] [Related]
5. lncRNA NEAT1 promotes cell proliferation and invasion by regulating miR‑365/RGS20 in oral squamous cell carcinoma.
Huang G; He X; Wei XL
Oncol Rep; 2018 Apr; 39(4):1948-1956. PubMed ID: 29484420
[TBL] [Abstract][Full Text] [Related]
6. Notch signalling induces epithelial‑mesenchymal transition to promote metastasis in oral squamous cell carcinoma.
Zhang J; Zheng G; Zhou L; Li P; Yun M; Shi Q; Wang T; Wu X
Int J Mol Med; 2018 Oct; 42(4):2276-2284. PubMed ID: 30015856
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of NEAT1 exerts suppressive effects on diabetic retinopathy progression via inactivating TGF-β1 and VEGF signaling pathways.
Shao K; Xi L; Cang Z; Chen C; Huang S
J Cell Physiol; 2020 Dec; 235(12):9361-9369. PubMed ID: 32356340
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
9. LINC01355 Contributes to Malignant Phenotype of Oral Squamous Cell Carcinoma and Cytotoxic T Cell Infiltration via Activating Notch Signaling Pathway.
Zou C; Wu S; Wei H; Luo H; Tang Z; Li X; Lv X; Ai Y
J Immunol Res; 2021; 2021():1830790. PubMed ID: 34355042
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
[TBL] [Abstract][Full Text] [Related]
11. Exploring the lncRNA-VEGF axis: Implications for cancer detection and therapy.
Alharthi NS; Al-Zahrani MH; Hazazi A; Alhuthali HM; Gharib AF; Alzahrani S; Altalhi W; Almalki WH; Khan FR
Pathol Res Pract; 2024 Jan; 253():154998. PubMed ID: 38056133
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
13. lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.
Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
Int J Oncol; 2019 Apr; 54(4):1183-1194. PubMed ID: 30720068
[TBL] [Abstract][Full Text] [Related]
14. Down-regulating NEAT1 inhibited the viability and vasculogenic mimicry formation of sinonasal squamous cell carcinoma cells via miR-195-5p/VEGFA axis.
Lu H; Kang F
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146672
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of
Hu Z; Liu X; Guo J; Zhuo L; Chen Y; Yuan H
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34713294
[TBL] [Abstract][Full Text] [Related]
16. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
Ji Y; Wang M; Li X; Cui F
Yonsei Med J; 2019 Apr; 60(4):336-345. PubMed ID: 30900419
[TBL] [Abstract][Full Text] [Related]
17. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
18. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma.
Kong XP; Yao J; Luo W; Feng FK; Ma JT; Ren YP; Wang DL; Bu RF
Mol Cell Biochem; 2014 Sep; 394(1-2):177-86. PubMed ID: 24889262
[TBL] [Abstract][Full Text] [Related]
19. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
Liu W; Yao Y; Shi L; Tang G; Wu L
J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
[TBL] [Abstract][Full Text] [Related]
20. Effects of lncRNA ANRIL on proliferation and apoptosis of oral squamous cell carcinoma cells by regulating TGF-β/Smad pathway.
Liu L; Ning SB; Fu S; Mao Y; Xiao M; Guo B
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6194-6201. PubMed ID: 31364119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]